Li_2023_Med.Oncol_40_110

Reference

Title : Stem cell-assisted enzyme\/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands - Li_2023_Med.Oncol_40_110
Author(s) : Li G , Nikkhoi SK , Hatefi A
Ref : Med Oncol , 40 :110 , 2023
Abstract : Li_2023_Med.Oncol_40_110
ESTHER : Li_2023_Med.Oncol_40_110
PubMedSearch : Li_2023_Med.Oncol_40_110
PubMedID: 36862260

Related information

Citations formats

Li G, Nikkhoi SK, Hatefi A (2023)
Stem cell-assisted enzyme\/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands
Med Oncol 40 :110

Li G, Nikkhoi SK, Hatefi A (2023)
Med Oncol 40 :110